Trending News

Sudeep Pharma IPO final day: GMP falls, issue gets strong subscription. Should you apply?

Sudeep Pharmas Rs 895-crore IPO enters its final bidding day with strong overall demand, led by robust NII and retail participation. Despite a softening grey-market premium, subscription momentum remains healthy. Backed by diversified excipient capabilities, steady financial growth and anchor interest, the company is positioned favourably as it approaches allotment and listing.